The Fund supports networks of state health policy decision makers to help identify, inspire, and inform policy leaders.
The Milbank Memorial Fund supports two state leadership programs for legislative and executive branch state government officials committed to improving population health.
The Fund identifies and shares policy ideas and analysis to advance state health leadership, strong primary care, healthy aging, and sustainable health care costs.
Keep up with news and updates from the Milbank Memorial Fund. And read the latest blogs from our thought leaders, including Fund President Christopher F. Koller.
The Fund publishes The Milbank Quarterly, as well as reports, issues briefs, and case studies on topics important to health policy leaders.
The Milbank Memorial Fund is is a foundation that works to improve population health and health equity.
Increasingly, hospitals have merged to form dominant health systems that can exert market power and charge anticompetitive prices that burden the… More
September 2021 Katherine L. Gudiksen, Alexandra D. Montague, Jaime S. King,
This brief explains how the provisions are used in practice to stifle competition, describes the variation in state laws, and offers best practices to state policymakers seeking to address provider market power. More
August 2021 Alexandra D. Montague, Katherine L. Gudiksen, Jaime S. King,
This brief, the second in a series on health care consolidation, examines the variation in state merger review practices across the country and identify the key elements of a comprehensive state merger review framework. More
August 2021 Katherine L. Gudiksen, Alexandra D. Montague, Amy Y. Gu, Jaime S. King,
This blog post discusses President Biden’s recent executive order, which illustrates the administration’s focus on revitalizing competition across the country through a “whole of government” approach that encourages the federal agencies to leverage their knowledge, data, and resources in support of competition. More
June 2021 Katherine L. Gudiksen, Alexandra D. Montague, Jaime S. King,
In the first of a series of three Milbank issue briefs, Katherine L. Gudiksen, Alexandra D. Montague, and Jaime S. King of The Source for Healthcare Price and Competition describe actions taken by federal and state policymakers to address the consequences of health care provider concentration through increased price transparency, improved merger review, oversight of anticompetitive conduct, and increased competition through a public option. More
April 2021 Rachel Block,
An overview of the state and local markets in Rhode Island, factors that the Federal Trade Commission (FTC) considers when analyzing proposed mergers, and the state’s policy options for a proposed merger. More
March 2021 Rachel Block, Kevin McAvey,
Nevertheless, with the passage of the No Surprises Act in December 2020, Congress took several steps to protect those most acutely impacted by our system’s lack of transparency and to invest in state data capacity to better understand local health care markets. More
September 2020 Rob Waters,
Rob Waters explores whether the Sutter Health settlement in California can serve as a roadmap for other states looking to control rising health care prices, as well as broader efforts for reining in hospital price inflation, such as antimerger legislation and the use of state price controls. More
August 2020 Charles Milligan,
The pursuit of value over volume remains an epic quest in health care. Motivated to discourage overutilization of services, and by the importance of… More
January 2020 Elizabeth Mitchell,
The recent settlement of the antitrust lawsuits against the Sutter Health System in California could be a watershed moment in the evolution of US health care markets and public policy, says Elizabeth Mitchell, president and CEO of the Pacific Business Group on Health in a new Milbank blog post. More
Get the Latest from the Milbank Memorial Fund
An endowed operating foundation that engages in nonpartisan analysis, collaboration, and communication, with an emphasis on state health policy.